EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Germline Variants in Sporadic Pituitary Adenomas

Ali S Alzahrani iD, Abdulghani Bin Nafisah, Meshael Alswailem, Balgees Alghamdi, Burair Alsaihati, Hussain Aljafar, Batoul Baz, Hindi Alhindi, Yosra Moria, Muhammad Imran Butt, Abdulrahman Ghiatheddin Alkabbani, Omalkhaire M Alshaikh und 7 weitere

Journal of the Endocrine Society · 06.04.2024 · 8 (6)

DOI: 10.1210/jendso/bvae085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 24.04.2024. Verfasst von Ali S Alzahrani und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, King Faisal Specialist Hospital & Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Data on germline genetics of pituitary adenomas (PAs) using whole-exome sequencing (WES) are limited.

Objective

This study investigated the germline genetic variants in patients with PAs using WES.

Methods

We studied 134 consecutive functioning (80.6%) and nonfunctioning (19.4%) PAs in 61 female (45.5%) and 73 male patients (54.5%). Their median age was 34 years (range, 11-85 years) and 31 patients had microadenomas (23.0%) and 103 macroadenomas (77%). None of these patients had family history of PA or a known PA-associated syndrome. Peripheral blood DNA was isolated and whole-exome sequenced. We used American College of Medical Genetics and Genomics (ACMG) criteria and a number of in silico analysis tools to characterize genetic variant pathogenicity levels and focused on previously reported PA-associated genes.

Results

We identified 35 variants of unknown significance (VUS) in 17 PA-associated genes occurring in 40 patients (29.8%). Although designated VUS by the strict ACGM criteria, they are predicted to be pathogenic by in silico analyses and their extremely low frequencies in 1000 genome, gnomAD, and the Saudi Genome Project databases. Further analysis of these variants by the Alpha Missense analysis tool yielded 8 likely pathogenic variants in 9 patients in the following genes: AIP:c.767C>T (p.S256F), CDH23:c.906G>C (p.E302D), CDH23:c.1096G>A (p.A366T), DICER1:c.620C>T (p.A207V), MLH1:c.955G>A (p.E319K), MSH2:c.148G>A (p.A50T), SDHA:c.869T>C (p.L290P) and USP48 (2 patients): c.2233G>A (p.V745M).

Conclusion

This study suggests that about 6.7% of patients with apparently sporadic PAs carry likely pathogenic variants in PA-associated genes. These findings need further studies to confirm them.

Schlagwörter

Stichwörter der Autor:innen

geneticsgermline variantsmolecular genetics of pituitary adenomaspituitary adenomapituitary gland tumors

Autor:innen und Institutionen

  • Department of Medicine, King Faisal Specialist Hospital & Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
  • Department of Molecular Oncology, King Faisal Specialist Hospital & Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
  • Applied Genomic Technologies Institute, King Abdulaziz City for Science and Technology, P.O. Box 6086, Riyadh 11442, Saudi Arabia.
  • Health and Wellness Sector, King Abdulaziz City for Science and Technology, P.O. Box 6086, Riyadh 11442, Saudi Arabia.
  • Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital & Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
  • Internal Medicine, King Salman Bin Abdulaziz Hospital, Riyadh 12769, Saudi Arabia.

ORCID-Profile: Ali S Alzahrani

Zitieren

APA

Alzahrani, A. S., Bin Nafisah, A., Alswailem, M., Alghamdi, B., Alsaihati, B., Aljafar, H., Baz, B., Alhindi, H., Moria, Y., Butt, M. I., Alkabbani, A. G., Alshaikh, O. M., Alnassar, A., Bin Afeef, A., AlQuraa, R., Alsuhaibani, R., Alhadlaq, O., Abothenain, F., & Altwaijry, Y. A. (2024). Germline Variants in Sporadic Pituitary Adenomas. Journal of the Endocrine Society, 8(6). https://doi.org/10.1210/jendso/bvae085

Vancouver

Alzahrani AS, Bin Nafisah A, Alswailem M, Alghamdi B, Alsaihati B, Aljafar H, et al. Germline Variants in Sporadic Pituitary Adenomas. Journal of the Endocrine Society. 2024;8(6). doi:10.1210/jendso/bvae085

BibTeX
@article{Alzahrani2024,
  author = {Alzahrani, Ali S and Bin Nafisah, Abdulghani and Alswailem, Meshael and Alghamdi, Balgees and Alsaihati, Burair and Aljafar, Hussain and Baz, Batoul and Alhindi, Hindi and Moria, Yosra and Butt, Muhammad Imran and Alkabbani, Abdulrahman Ghiatheddin and Alshaikh, Omalkhaire M and Alnassar, Anhar and Bin Afeef, Ahmed and AlQuraa, Reem and Alsuhaibani, Rawan and Alhadlaq, Omar and Abothenain, Fayha and Altwaijry, Yasser A},
  title = {Germline Variants in Sporadic Pituitary Adenomas},
  journal = {Journal of the Endocrine Society},
  year = {2024},
  volume = {8},
  number = {6},
  doi = {10.1210/jendso/bvae085}
}
Kostenlos starten →